COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
The CDC’s recent decision to harmonize recommendations for respiratory viruses has the public and infectious disease societies in support.
The lower-case fatality rate of the Omicron variant is overridden by its high infectivity, increasing the chances of becoming severely sick from participating in social activities. The Omicron wave was associated with some of the highest community rates of deaths and hospitalizations during the pandemic. SARS-CoV-2 is much more infectious than influenza,
However, we need to ask: Should SARS-CoV-2, with its frequent period of asymptomatic spread and high infectivity, be harmonized with other non-ACE2 receptor respiratory viruses? And is COVID-19 even a respiratory illness, as opposed to a multi-system disease that can masquerade in many different forms, similar to syphilis?
A better prevention harmonization may well be with the measles and polio viruses.
- Before 1963,
measles caused an estimated 3 to 4 million cases annually, 48,000 reported hospitalizations, 1,000 cases of encephalitis, and 400 to 500 deaths.Measles is one of themost infectious diseases known to man and similar to COVID-19, it spreads through contact with surfaces and aerosolization. - Polio is even more elusive.
Over 50% of individuals are asymptomatic , and approximately 25% of people have influenza-like symptoms. One to 5% of patients develop meningitis, 0.5 to 0.05% will develop paralysis, and between 0.05 to 0.001% will die.
Measles and polio cases mainly affect the young, but as a senior citizen, I can testify that life and livelihood at all ages are just as precious.
The impending loss of herd immunity for measles is an ominous development. Measles is a DNA virus and thus has a lower mutation rate than SARS-CoV-2, but it still can mutate. Historically, there was a rapid uptake of the measles vaccine, and the spread was halted. But now the virus is spreading and mutating. Already, a strain of
COVID-19 is still ravaging our society, with
We need to ask, if we are allowing asymptomatic individuals with COVID-19 to mingle in our community, how can we effectively message the public to increase their vigilance and vaccination rates for diseases with similar or even less severe outcomes?
The mantra that “we are now in a better place” gives a misleading impression. We are still in a dangerous place that requires increased vigilance and strategies to prevent infectious diseases.
I started my medical career attending to cancer patients. I would hear the pleading from patients and their friends, trying to minimize the disease and avoid treatments. But you cannot bargain with cancer, nor can you with COVID-19. The virus does not care what society is willing to do; it only exists to reproduce and, in its wake, is left with death and disability.
Newsletter
Related Articles
- Bug of the Month: I'm Older Than Empires
September 16th 2025
- Top 5 Infection Prevention Articles of Summer 2025
September 16th 2025
- From Outbreak to Zoopocalypse: 11 More Must-Watch Viral Thrillers
September 15th 2025
- Debunking the Mistruths and Misinformation About COVID-19
September 15th 2025
- Bug of the Month: I Like to Hitch a Ride
September 12th 2025